Lunai Bioworks (LNAI) Cash from Investing Activities (2011 - 2025)
Lunai Bioworks (LNAI) recorded quarterly Cash from Investing Activities of -$1238.0 in Q4 2025, down 100.23% quarter-over-quarter from $544700.0 in Q3 2025.
Lunai Bioworks (LNAI) Cash from Investing Activities (2011 - 2025) Analysis & Trends
Lunai Bioworks' Cash from Investing Activities history runs 13 years deep, the most recent figure standing at -$1238.0 for Q4 2025.
- In Q4 2025, Cash from Investing Activities changed N/A year-over-year to -$1238.0; the TTM figure through Mar 2026 stood at $1.5 million (changed N/A YoY), while the FY2025 annual figure was -$500000.0, up 60.32% from the prior year.
- Cash from Investing Activities was -$1238.0 for Q4 2025 at Lunai Bioworks, down from $544700.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $964389.0 in Q2 2025 to a low of -$1.1 million in Q3 2023.
- Historically, Cash from Investing Activities has averaged $19820.4 across 4 years, with a median of -$22156.0 in 2021.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities sank 769.13% in 2024, then soared 1906.89% in 2025.
- A 4-year view of Cash from Investing Activities shows it stood at -$5156.0 in 2021, then plunged by 1011.99% to -$57334.0 in 2023, then rose by 6.91% to -$53373.0 in 2024, then jumped by 97.68% to -$1238.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$1238.0 (Q4 2025), $544700.0 (Q3 2025), and $964389.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 579,519.10 |
| 10 | Lunai Bioworks | 95.85 Mn | 92.70 Mn | 20,942.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,238.00 |
| Dec 31, 2025 | -1,238.00 |
| Sep 30, 2025 | 544,700.00 |
| Sep 30, 2025 | 544,700.00 |
| Jun 30, 2025 | 964,389.00 |
| Jun 30, 2025 | 964,389.00 |
| Jun 30, 2024 | -53,373.00 |
| Jun 30, 2024 | -53,373.00 |
| Mar 31, 2024 | -91,597.00 |
| Mar 31, 2024 | -91,597.00 |
| Dec 31, 2023 | -57,334.00 |
| Dec 31, 2023 | -57,334.00 |
| Sep 30, 2023 | -1.06 Mn |
| Sep 30, 2023 | -1.06 Mn |
| Jun 30, 2023 | -6,141.00 |
| Jun 30, 2023 | -6,141.00 |
| Sep 30, 2021 | -5,156.00 |
| Sep 30, 2021 | -5,156.00 |
| Jun 30, 2021 | -38,171.00 |
| Jun 30, 2021 | -38,171.00 |